Procurement Summary
Country : USA
Summary : Notice of Intent to sole source for the Chemiluminescent immunoassay (CLIA) kits compatible with the government-s current CLIA instrumentation for the Brooke Army Medical Center (BAMC).
Deadline : 19 Apr 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 117216608
Document Ref. No. : W81K00-25-Q-A057
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
The Department of Pathology and Area Laboratory Services (DPALS) seeks to establish a cost-per-kit agreement to include reagents, consumables, controls, and any necessary products to conduct testing to include: Calprotectin, Cytomegalovirus, Epstein-Barr virus (viral capsid antigens, nuclear antigens, and early antigen-diffuse), Herpes Simplex Virus ½, Measles, Mumps, Rubella, Toxoplasma gondii, Varicella Zoster, Zika virus, Lyme disease, and an assay capable of rapidly differentiating between bacterial and viral infections in acute settings (MeMed BV or similar) compatible with the government-s current Diasorin Liaison xL Chemiluminescence Immunoassay (CLIA) instrumentation for the Department of Pathology & Area Laboratory Services Molecular Laboratory at Brooke Army Medical Center (BAMC), Fort Sam Houston Tx.
Active Contract Opportunity
Notice ID : W81K00-25-Q-A057
Related Notice
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEPT OF THE ARMY
Major Command : US ARMY MEDICAL COMMAND
General Information
Contract Opportunity Type: Special Notice (Original)
Original Published Date: Apr 03, 2025 03:08 pm CDT
Original Response Date: Apr 19, 2025 04:00 pm CDT
Inactive Policy: 15 days after response date
Original Inactive Date: May 04, 2025
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing
Place of Performance: JBSA Ft Sam Houston, Tx 78234 USA
Documents
Tender Notice
Redacted-JA-Sole-Source-CLIA-Reagents-Fully-E.pdf